A mixed clinicopathological and molecular proxy of homologous recombination deficiency in triple negative breast cancer
Clinical models are increasingly employed in medical science as either diagnostic or prognostic aids. Machine-learning methods are able to draw links in large data that can be used to predict patient risk and allow more informed decisions regarding treatment and medication intervention. An advanced clinical predictor, HRDetect, can determine loss of homologous recombination-based repair pathways i
